ScholarIQanswers from OpenAlex & ORCID
Aude Roborel de Climens
ResearcherPublications, citations & collaboration network
Aude Roborel de Climens is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Aude Roborel de Climens have?
ScholarIQindexed works
Aude Roborel de Climens has 45 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Aude Roborel de Climens have?
ScholarIQcitation count
Aude Roborel de Climens has 637 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Aude Roborel de Climens?
ScholarIQh-index
Aude Roborel de Climens has an h-index of 14 in OpenAlex.
What is the i10-index of Aude Roborel de Climens?
ScholarIQi10-index
Aude Roborel de Climens has an i10-index of 18 in OpenAlex.
What is the ORCID of Aude Roborel de Climens?
ScholarIQorcid
The ORCID for Aude Roborel de Climens is on the source record.
What is the OpenAlex record for Aude Roborel de Climens?
ScholarIQopenalex
The OpenAlex for Aude Roborel de Climens is on the source record.
What are the most-cited papers on Aude Roborel de Climens?
ScholarIQmost cited works
The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase
Brent J. Passer, Vanessa Nancy-Portebois, Nathalie Amzallag, Sylvie Prieur, Christophe Cans, Aude Roborel de Climens, Giusy Fiucci, Véronique Bouvard, Marcel Tuynder, Laurent Susini, Stéphanie Morchoisne, Virginie Crible, Alexandra Lespagnol, J Dausset, Moshe Oren, Robert Amson, Adam Telerman
Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia
Delphine Poncet, Aurélie Belleville, Claire T'Kint de Roodenbeke, Aude Roborel de Climens, Elsa Ben Simon, Hélène Merle‐Béral, Evelyne Callet‐Bauchu, Gilles Salles, Laure Sabatier, Jozo Delić, Éric Gilson
Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes
David Russell‐Jones, Arnaud Dauchy, Elías Delgado, George Dimitriadis, Hans Frandsen, Luiza Popescu, Bernd Schultes, Krzysztof Strojek, Mireille Bonnemaire, Aude Roborel de Climens, Melanie J. Davies
Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK
Aude Roborel de Climens, Émilie Pain, Anders Boss, Alka Shaunik
Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy
Aude Roborel de Climens, Kaan Tunceli, Benoît Arnould, N. Germain, Kristy Iglay, Josephine M. Norquist, Kimberly G. Brodovicz